GlassScriptPhysician profile
Bryce Lavell Hancock
NPI 1457309668
$17,488.72
in general payments reported to CMS, 2019-2025
52 companies · $3,702 in 2025
The $3,702 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,232 · 2022: $2,817 · 2023: $2,406 · 2024: $7,332 · 2025: $3,702.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,023 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,580 · Travel and Lodging: $2,547 · Education: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,022.86 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,580.00 |
| Travel and Lodging | $2,547.04 |
| Education | $289.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $4,911.73 | 2021-2025 | |
| Inspire Medical Systems, INC. | $3,948.34 | 2022-2025 | Inspire |
| Harmony Biosciences LLC | $1,039.93 | 2021-2025 | Wakix |
| Abbvie INC. | $971.71 | 2021-2025 | |
| Lilly USA, LLC | $767.58 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Axsome Therapeutics, INC. | $577.77 | 2022-2025 | Sunosi |
| Astrazeneca Pharmaceuticals LP | $534.63 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Avadel Cns Pharmaceuticals, LLC | $492.14 | 2023-2025 | Lumryz |
| Novo Nordisk INC | $488.12 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $314.30 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $280.60 | 2021-2025 | Jardiance, Tradjenta, Synjardy |
| Amgen INC. | $260.13 | 2021-2025 | Repatha, Evenity, Otezla |
| Astellas Pharma US INC | $240.13 | 2022-2024 | Veozah |
| Glaxosmithkline, LLC. | $237.76 | 2023-2025 | Arexvy, Shingrix |
| Sanofi-Aventis U.S. LLC | $228.08 | 2021-2025 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $220.80 | 2022-2025 | |
| Idorsia Pharmaceuticals US INC | $175.36 | 2023-2024 | Quviviq |
| Dexcom, INC. | $160.15 | 2021-2024 | Dexcom G6 Transmitter |
| Abbott Laboratories | $127.99 | 2021-2025 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $115.16 | 2021-2025 | Verquvo, Capvaxive, Steglatro |
| Daiichi Sankyo INC. | $100.13 | 2021-2025 | Injectafer |
| Sanofi Pasteur INC. | $97.67 | 2022-2025 | |
| Actelion Pharmaceuticals US, INC. | $97.33 | 2021-2025 | Opsumit |
| Pfizer INC. | $80.11 | 2025 | |
| Fisher & Paykel Healthcare INC | $79.94 | 2021-2025 | Fisher & Paykel Healthcare |
| Sumitomo Pharma America, INC. | $69.58 | 2023-2024 | Gemtesa |
| E.R. Squibb & Sons, L.L.C. | $69.30 | 2021-2023 | Eliquis |
| Sunovion Pharmaceuticals INC. | $57.15 | 2021-2022 | |
| Baxter Healthcare | $56.27 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Arbor Pharmaceuticals, INC. | $55.83 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $51.63 | 2023-2024 | Ingrezza, Ongentys |
| Boston Scientific Corporation | $50.66 | 2021-2023 | Wavewriter Alpha Prime 16, Watchman Access System |
| Phathom Pharmaceuticals, INC. | $41.52 | 2024-2025 | Voquezna |
| Philips North America LLC | $41.00 | 2024-2025 | Patient Interface Software, (Di7) Home Pi Undivided |
| Biohaven Pharmaceutical Holding Company LTD. | $39.94 | 2022 | |
| Janssen Pharmaceuticals, INC | $38.98 | 2023-2024 | Spravato, Xarelto |
| Avanir Pharmaceuticals, INC. | $38.06 | 2021-2022 | |
| Antares Pharma, INC. | $37.67 | 2021 | |
| Eisai INC. | $34.26 | 2021 | |
| 3b Medical, INC. | $32.47 | 2025 | Luna |
| Amarin Pharma, INC. | $29.22 | 2021 | |
| Hologic Sales and Service, LLC | $27.38 | 2022 | |
| Madrigal Pharmaceuticals | $25.94 | 2025 | Rezdiffra |
| Resmed Corp | $20.39 | 2022 | |
| Biogen, INC. | $18.52 | 2021 | |
| Radius Health, INC. | $18.43 | 2024 | Tymlos |
| Lundbeck LLC | $17.49 | 2023 | Rexulti |
| Averitas Pharma INC. | $14.71 | 2024 | Qutenza |
| Almatica Pharma LLC | $14.65 | 2023 | Loreev Xr |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.06 | 2024 | Caplyta |
| Grifols USA, LLC | $13.56 | 2024 | Prolastin-C Liquid |
| Neurelis, INC. | $12.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryce Hancock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.